688293 奥浦迈
已收盘 11-22 15:00:01
资讯
新帖
简况
奥浦迈股价涨5% 回购股份注销
智选洞察 · 11-20 10:11
奥浦迈股价涨5% 回购股份注销
奥浦迈:11月14日接受机构调研,淡水泉(北京)投资管理有限公司、东方证券(自营)等多家机构参与
证券之星 · 11-19
奥浦迈:11月14日接受机构调研,淡水泉(北京)投资管理有限公司、东方证券(自营)等多家机构参与
奥浦迈做LP,出资道彤投资
投资界 · 11-18
奥浦迈做LP,出资道彤投资
奥浦迈11月18日主力资金流入439万元 连续5日加仓
市场透视 · 11-18
奥浦迈11月18日主力资金流入439万元 连续5日加仓
奥浦迈股东国寿成达减持1%股份,持股降至6.91%
财中社 · 11-15
奥浦迈股东国寿成达减持1%股份,持股降至6.91%
11月15日奥浦迈发布公告,其股东减持114.77万股
证券之星 · 11-15
11月15日奥浦迈发布公告,其股东减持114.77万股
奥浦迈(688293.SH)主要股东国寿成达减持比例达1%
智通财经 · 11-15
奥浦迈(688293.SH)主要股东国寿成达减持比例达1%
11月15日奥浦迈跌5.98%,汇丰晋信龙腾混合A基金重仓该股
证券之星 · 11-15
11月15日奥浦迈跌5.98%,汇丰晋信龙腾混合A基金重仓该股
奥浦迈11月15日获主力加仓1333万元 环比增加484.65%
市场透视 · 11-15
奥浦迈11月15日获主力加仓1333万元 环比增加484.65%
奥浦迈大跌5.03% 6家券商给予增持建议
智选洞察 · 11-15
奥浦迈大跌5.03% 6家券商给予增持建议
奥浦迈11月14日主力资金流入228万元 连续3日加仓
市场透视 · 11-14
奥浦迈11月14日主力资金流入228万元 连续3日加仓
奥浦迈大幅上涨 获融资净买入2378万元
智选洞察 · 11-13
奥浦迈大幅上涨 获融资净买入2378万元
奥浦迈:11月6日接受机构调研,包括知名机构明汯投资,聚鸣投资,正心谷资本的多家机构参与
证券之星 · 11-12
奥浦迈:11月6日接受机构调研,包括知名机构明汯投资,聚鸣投资,正心谷资本的多家机构参与
【机构调研记录】浙商基金调研奥浦迈
证券之星 · 11-12
【机构调研记录】浙商基金调研奥浦迈
【机构调研记录】华宝基金调研宏发股份、奥浦迈等3只个股(附名单)
证券之星 · 11-12
【机构调研记录】华宝基金调研宏发股份、奥浦迈等3只个股(附名单)
奥浦迈大幅上涨 获6家券商给予增持建议
智选洞察 · 11-11
奥浦迈大幅上涨 获6家券商给予增持建议
奥浦迈:Q3培养基高增 税率变动影响短期利润 海外市场增长亮眼
国盛证券 · 11-08
奥浦迈:Q3培养基高增 税率变动影响短期利润 海外市场增长亮眼
【机构调研记录】诺安基金调研国泰集团、奥浦迈等4只个股(附名单)
证券之星 · 11-06
【机构调研记录】诺安基金调研国泰集团、奥浦迈等4只个股(附名单)
【机构调研记录】汇丰晋信基金调研华勤技术、奥浦迈等4只个股(附名单)
证券之星 · 11-06
【机构调研记录】汇丰晋信基金调研华勤技术、奥浦迈等4只个股(附名单)
【机构调研记录】宝盈基金调研国泰集团、奥浦迈等3只个股(附名单)
证券之星 · 11-06
【机构调研记录】宝盈基金调研国泰集团、奥浦迈等3只个股(附名单)
加载更多
公司概况
公司名称:
上海奥浦迈生物科技股份有限公司
所属行业:
研究和试验发展
上市日期:
2022-09-02
主营业务:
上海奥浦迈生物科技股份有限公司是一家专门从事细胞培养产品与服务的高新技术企业。公司以细胞培养技术和工艺开发为基础,主营业务涉及细胞培养基系列产品和生物药委托开发生产服务两大应用领域。公司的主要产品有目培养基业务、CDMO业务、CHO培养基、293培养基。公司及其子公司已获得5项发明专利,62项实用新型专利和2项外观专利。公司获得“高新技术企业”、上海市“专精特新”、上海市科技小巨人培育企业等称号。
发行价格:
80.20
{"stockData":{"symbol":"688293","market":"SH","secType":"STK","nameCN":"奥浦迈","latestPrice":42.78,"timestamp":1732258801000,"preClose":44.36,"halted":0,"volume":525486,"delay":0,"floatShares":78633000,"shares":114999999,"eps":0.3319,"marketStatus":"已收盘","marketStatusCode":5,"change":-1.58,"latestTime":"11-22 15:00:01","open":44.36,"high":44.36,"low":42.62,"amount":22766300,"amplitude":0.0392,"askPrice":42.8,"askSize":2,"bidPrice":42.78,"bidSize":232,"shortable":0,"etf":0,"ttmEps":0.3319,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732498200000},"adr":0,"adjPreClose":44.36,"symbolType":"stock_kcb","openAndCloseTimeList":[[1732239000000,1732246200000],[1732251600000,1732258800000]],"highLimit":48.8,"lowLimit":39.92,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":114772460,"pbRate":2.34,"roa":"--","roe":"1.26%","epsLYR":0.47,"committee":0.643836,"marketValue":4910000000,"floatMarketCap":3364000000,"peRate":128.894245,"changeRate":-0.0356,"turnoverRate":0.0067,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2024-11-25。","afterMarket":{"amount":0,"volume":0,"close":42.78,"buyVolume":0,"sellVolume":0,"time":1732260839464,"indexStatus":"已收盘 11-22 15:30:00","preClose":44.36}},"requestUrl":"/m/hq/s/688293","defaultTab":"news","newsList":[{"id":"2484213384","title":"奥浦迈股价涨5% 回购股份注销","url":"https://stock-news.laohu8.com/highlight/detail?id=2484213384","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484213384?lang=zh_cn&edition=full","pubTime":"2024-11-20 10:11","pubTimestamp":1732068671,"startTime":"0","endTime":"0","summary":"11月20日,奥浦迈股价大幅上涨,截至10点11分,奥浦迈上涨5.01%,报45.09元/股,成交953万元,换手率0.28%,振幅6.45%。主营业务及业绩奥浦迈公司主营业务为从事细胞培养产品与服务。最新财报显示,今年三季报,奥浦迈实现营业收入2.16亿元,同比增长25.73%,净利润为2,723.48万元,同比减少36.93%,基本每股收益为0.24元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120101132a2473c8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120101132a2473c8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688293"],"gpt_icon":0},{"id":"2484958403","title":"奥浦迈:11月14日接受机构调研,淡水泉(北京)投资管理有限公司、东方证券(自营)等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2484958403","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484958403?lang=zh_cn&edition=full","pubTime":"2024-11-19 09:33","pubTimestamp":1731980027,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年11月18日奥浦迈发布公告称公司于2024年11月14日接受机构调研,淡水泉(北京)投资管理有限公司、东方证券(自营)、长信基金管理有限责任公司、东吴基金管理有限公司、大成基金管理有限公司、招商基金管理有限公司、汇添富基金管理股份有限公司、银华基金管理股份有限公司、嘉实基金管理有限公司、华富基金管理有限公司、国泰基金管理有限公司、天风(上海)证券资产管理有限公司参与。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111900008816.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0183","688293","600958","BK1147","03958","BK1564","BK0216","BK0012","BK0276","BK0028"],"gpt_icon":0},{"id":"2484304644","title":"奥浦迈做LP,出资道彤投资","url":"https://stock-news.laohu8.com/highlight/detail?id=2484304644","media":"投资界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484304644?lang=zh_cn&edition=full","pubTime":"2024-11-18 17:52","pubTimestamp":1731923520,"startTime":"0","endTime":"0","summary":"投资界-解码LP获悉,近日,奥浦迈发布公告,公司拟出资不超过3亿元参与设立产业投资基金。基金暂定名上海奥创前景创业投资基金合伙企业,基金管理人为苏州道彤淳辉创业投资管理有限公司,募集资金总规模为人民币10亿元。道彤投资成立于2015年,是一家专注于生命科学领域中早期投资及产业并购的风险投资公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118175711abcc3028&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118175711abcc3028&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688293"],"gpt_icon":0},{"id":"2484161424","title":"奥浦迈11月18日主力资金流入439万元 连续5日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2484161424","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484161424?lang=zh_cn&edition=full","pubTime":"2024-11-18 15:21","pubTimestamp":1731914468,"startTime":"0","endTime":"0","summary":"11月18日, 奥浦迈股价涨0.38%,报收41.86元,成交金额2791万元,换手率0.84%,振幅5.54%,量比0.37。奥浦迈今日主力资金净流入439万元,连续5日净流入,上一交易日主力净流入1333万元,今日环比减少67.07%。近一年数据显示,该股主力连续5日净流入后,次日上涨概率为33.33%,平均涨幅为3.01%。该股近5个交易日下跌8.20%,主力资金累计净流入4076万元;近20日主力资金累计净流入2571万元,其中净流入天数为11日。该股主力净额占比0.13%,A股市场排名535/5000,高于行业平均值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118154457a2423504&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118154457a2423504&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688293"],"gpt_icon":0},{"id":"2483321982","title":"奥浦迈股东国寿成达减持1%股份,持股降至6.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483321982","media":"财中社","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483321982?lang=zh_cn&edition=full","pubTime":"2024-11-15 19:18","pubTimestamp":1731669488,"startTime":"0","endTime":"0","summary":"根据公告,国寿成达(上海)健康产业股权投资中心在2024年11月7日至2024年11月15日期间通过集中竞价交易减持公司股份115万股,占公司总股本1.15亿股的比例为1.00%。减持后,国寿成达持有公司股份数量由908万股减少至793万股,持股比例由7.91%降至6.91%。此次减持不触及要约收购,也不会导致公司控股股东及实际控制人发生变化。2024年前三季度,奥浦迈实现收入2.16亿元,归母净利润2723万元。文章来源:财中社奥浦迈股东国寿成达减持1%股份,持股降至6.91%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115192922a23af4a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115192922a23af4a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688293"],"gpt_icon":0},{"id":"2483534708","title":"11月15日奥浦迈发布公告,其股东减持114.77万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483534708","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483534708?lang=zh_cn&edition=full","pubTime":"2024-11-15 18:01","pubTimestamp":1731664862,"startTime":"0","endTime":"0","summary":"证券之星消息,11月15日奥浦迈发布公告《奥浦迈:关于持股5%以上股东减持比例达到1%的提示性公告》,其股东国寿成达(上海)健康产业股权投资中心(有限合伙)于2024年11月7日至2024年11月15日间合计减持114.77万股,占公司目前总股本的1.0%,变动期间该股股价上涨1.51%,截止11月15日收盘报41.7元。股东增减持详情见下表:根据奥浦迈2024年三季报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111500031617.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"gpt_icon":0},{"id":"2483492653","title":"奥浦迈(688293.SH)主要股东国寿成达减持比例达1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483492653","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483492653?lang=zh_cn&edition=full","pubTime":"2024-11-15 17:04","pubTimestamp":1731661485,"startTime":"0","endTime":"0","summary":"智通财经APP讯,奥浦迈(688293.SH)公告,公司持股5%以上股东国寿成达(上海)健康产业股权投资中心(有限合伙)(简称“国寿成达”)于2024年11月7日至2024年11月15日期间通过集中竞价交易的方式合计减持公司股份114.77万股,占公司总股本比例为1.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1211553.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","688293"],"gpt_icon":0},{"id":"2483348725","title":"11月15日奥浦迈跌5.98%,汇丰晋信龙腾混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483348725","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483348725?lang=zh_cn&edition=full","pubTime":"2024-11-15 16:09","pubTimestamp":1731658181,"startTime":"0","endTime":"0","summary":"证券之星消息,11月15日奥浦迈跌5.98%,收盘报41.7元,换手率1.64%,成交量1.29万手,成交额5446.36万元。根据2024基金Q3季报公募基金重仓股数据,重仓该股的公募基金共8家,其中持有数量最多的公募基金为汇丰晋信龙腾混合A。汇丰晋信龙腾混合A目前规模为9.1亿元,最新净值1.2776,较上一交易日下跌2.53%,近一年上涨4.28%。汇丰晋信龙腾混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111500025101.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"gpt_icon":0},{"id":"2483348345","title":"奥浦迈11月15日获主力加仓1333万元 环比增加484.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483348345","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483348345?lang=zh_cn&edition=full","pubTime":"2024-11-15 15:20","pubTimestamp":1731655232,"startTime":"0","endTime":"0","summary":"11月15日, 奥浦迈股价跌5.98%,报收41.70元,成交金额5446万元,换手率1.64%,振幅7.55%,量比0.70。奥浦迈今日主力资金净流入1333万元,连续4日净流入,上一交易日主力净流入228万元,今日环比增加484.65%。近一年数据显示,该股主力连续4日净流入后,次日上涨概率为66.67%,平均涨幅为0.49%。该股近5个交易日上涨1.71%,主力资金累计净流入3545万元,其中3个交易日为股价下跌时净流入;近20日主力资金累计净流入2110万元,其中净流入天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115153459a23a2623&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115153459a23a2623&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688293"],"gpt_icon":0},{"id":"2483393640","title":"奥浦迈大跌5.03% 6家券商给予增持建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2483393640","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483393640?lang=zh_cn&edition=full","pubTime":"2024-11-15 10:38","pubTimestamp":1731638339,"startTime":"0","endTime":"0","summary":"11月15日,奥浦迈股价大幅下跌,截至10点38分,奥浦迈下跌5.03%,报42.12元/股,成交2316万元,换手率0.69%,振幅5.03%。此外,数据统计显示,近半年内6家券商给予增持建议,5家券商给予买入建议。主营业务及业绩奥浦迈公司主营业务为从事细胞培养产品与服务。最新财报显示,今年三季报,奥浦迈实现营业收入2.16亿元,同比增长25.73%,净利润为2,723.48万元,同比减少36.93%,基本每股收益为0.24元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115105351abc2e786&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115105351abc2e786&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688293"],"gpt_icon":0},{"id":"2483846524","title":"奥浦迈11月14日主力资金流入228万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2483846524","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483846524?lang=zh_cn&edition=full","pubTime":"2024-11-14 15:20","pubTimestamp":1731568823,"startTime":"0","endTime":"0","summary":"11月14日, 奥浦迈股价跌3.59%,报收44.35元,成交金额4337万元,换手率1.25%,振幅7.39%,量比0.51。奥浦迈今日主力资金净流入228万元,连续3日净流入,上一交易日主力净流入290万元,今日环比减少21.38%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为45.45%,平均涨幅为2.62%。该股近5个交易日上涨11.01%,主力资金累计净流入1821万元,其中2个交易日为股价下跌时净流入;近20日主力资金累计净流入803万元,其中净流入天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114153908abc01c62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114153908abc01c62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688293"],"gpt_icon":0},{"id":"2483046837","title":"奥浦迈大幅上涨 获融资净买入2378万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483046837","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483046837?lang=zh_cn&edition=full","pubTime":"2024-11-13 13:12","pubTimestamp":1731474757,"startTime":"0","endTime":"0","summary":"11月13日,奥浦迈股价大幅上涨,截至13点12分,奥浦迈上涨5.01%,报46.15元/股,成交4994万元,换手率1.42%。资金动向截止发稿,奥浦迈获得主力净流入110万元,其中超大单流入203万元,大单流出93万元。最新财报显示,今年三季报,奥浦迈实现营业收入2.16亿元,同比增长25.73%,净利润为2,723.48万元,同比减少36.93%,基本每股收益为0.24元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113131242a2327e96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113131242a2327e96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688293","BK0216"],"gpt_icon":0},{"id":"2482617715","title":"奥浦迈:11月6日接受机构调研,包括知名机构明汯投资,聚鸣投资,正心谷资本的多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2482617715","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482617715?lang=zh_cn&edition=full","pubTime":"2024-11-12 10:34","pubTimestamp":1731378859,"startTime":"0","endTime":"0","summary":"奥浦迈主营业务:从事细胞培养产品与服务。该股最近90天内共有8家机构给出评级,买入评级5家,增持评级3家;过去90天内机构目标均价为36.0。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111200012044.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"gpt_icon":0},{"id":"2482979599","title":"【机构调研记录】浙商基金调研奥浦迈","url":"https://stock-news.laohu8.com/highlight/detail?id=2482979599","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482979599?lang=zh_cn&edition=full","pubTime":"2024-11-12 08:04","pubTimestamp":1731369865,"startTime":"0","endTime":"0","summary":"旗下最近一年表现最佳的公募基金产品为浙商智选领航三年持有混合A,最新单位净值为0.87,近一年增长20.5%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111200006301.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"gpt_icon":0},{"id":"2482795629","title":"【机构调研记录】华宝基金调研宏发股份、奥浦迈等3只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2482795629","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482795629?lang=zh_cn&edition=full","pubTime":"2024-11-12 08:02","pubTimestamp":1731369779,"startTime":"0","endTime":"0","summary":";公司产品已经成功应用到多个客户的多教智能眼镜及AR、VR硬件产品中华宝基金成立于2003年,截至目前,资产管理规模3234.45亿元,排名29/207;资产管理规模1636.77亿元,排名30/207;管理公募基金数233只,排名26/207;旗下公募基金经理41人,排名26/207。旗下最近一年表现最佳的公募基金产品为华宝中证金融科技主题ETF,最新单位净值为1.64,近一年增长46.55%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111200006253.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0169","BK0224","BK0185","BK0028","LU2213484517.USD","600885","BK0077","BK0196","LU1328615791.USD","BK0078","LU0227179875.USD","BK0175","LU1831875114.USD","688293","BK0216"],"gpt_icon":0},{"id":"2482224987","title":"奥浦迈大幅上涨 获6家券商给予增持建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2482224987","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482224987?lang=zh_cn&edition=full","pubTime":"2024-11-11 10:48","pubTimestamp":1731293326,"startTime":"0","endTime":"0","summary":"资金动向截止发稿,奥浦迈获得主力净流出242万元,其中超大单流出148万元,大单流出93万元。主营业务及业绩奥浦迈公司主营业务为从事细胞培养产品与服务。最新财报显示,今年三季报,奥浦迈实现营业收入2.16亿元,同比增长25.73%,净利润为2,723.48万元,同比减少36.93%,基本每股收益为0.24元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111104853abb47007&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111104853abb47007&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688293"],"gpt_icon":0},{"id":"2481127700","title":"奥浦迈:Q3培养基高增 税率变动影响短期利润 海外市场增长亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=2481127700","media":"国盛证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481127700?lang=zh_cn&edition=full","pubTime":"2024-11-08 00:00","pubTimestamp":1730995200,"startTime":"0","endTime":"0","summary":"奥浦迈发布2024 年三季度报告。观点:Q3 收入端高速增长,税率变更导致利润端阶段性承压,剔除税费影响后利润端正向改善。Q3 利润端阶段性承压,主要系公司被取消高新技术企业资格,自2024 年开始所得税税率由15%增至25%,Q3 集中补税导致利润端下滑。剔除因税率变动导致的税费影响后,2024Q3 归母净利润为808 万元,同比+52.48%,环比+77.14%,均实现正向改善。培养基延续高增态势,CDMO 业务逐季改善,海外市场增长势头强劲。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110819012095bdedb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110819012095bdedb1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688293"],"gpt_icon":0},{"id":"2481664966","title":"【机构调研记录】诺安基金调研国泰集团、奥浦迈等4只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2481664966","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481664966?lang=zh_cn&edition=full","pubTime":"2024-11-06 08:04","pubTimestamp":1730851478,"startTime":"0","endTime":"0","summary":"旗下最近一年表现最佳的公募基金产品为诺安积极回报混合A,最新单位净值为2.33,近一年增长52.88%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110600007742.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688293","603977","BK0229"],"gpt_icon":0},{"id":"2481664615","title":"【机构调研记录】汇丰晋信基金调研华勤技术、奥浦迈等4只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2481664615","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481664615?lang=zh_cn&edition=full","pubTime":"2024-11-06 08:04","pubTimestamp":1730851463,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及11月5日披露的机构调研信息,汇丰晋信基金近期对4家上市公司进行了调研,相关名单如下:1)华勤技术 个股亮点:公司是专业从事智能硬件产品的研发设计、生产制造和运营服务的平台型公司,主要服务于国内外知名的智能硬件品牌厂商及互联网公司等,如三星、OPPO、小米、vivo、亚马逊、联想、宏碁、华硕、索尼等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110600007721.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216","603296","BK0214"],"gpt_icon":0},{"id":"2481514664","title":"【机构调研记录】宝盈基金调研国泰集团、奥浦迈等3只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2481514664","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481514664?lang=zh_cn&edition=full","pubTime":"2024-11-06 08:03","pubTimestamp":1730851407,"startTime":"0","endTime":"0","summary":";全资子公司山西沁水新奥清洁能源有限公司主营液化天然气生产宝盈基金成立于2001年,截至目前,资产管理规模792.92亿元,排名69/207;资产管理规模514.46亿元,排名72/207;管理公募基金数120只,排名59/207;旗下公募基金经理18人,排名70/207。旗下最近一年表现最佳的公募基金产品为宝盈转型动力混合A,最新单位净值为1.18,近一年增长39.08%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110600007697.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603977","688293","BK0216","BK0229"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2022-09-02","address":"上海市浦东新区紫萍路908弄28号","stockEarnings":[{"period":"1week","weight":0.0259},{"period":"1month","weight":0.35},{"period":"3month","weight":0.639},{"period":"6month","weight":0.2193},{"period":"1year","weight":-0.2552},{"period":"ytd","weight":-0.2135}],"companyName":"上海奥浦迈生物科技股份有限公司","boardCode":"AI0073","perCapita":"24696股","boardName":"研究和试验发展","registeredCapital":"11477万元","compareEarnings":[{"period":"1week","weight":-0.0191},{"period":"1month","weight":-0.0108},{"period":"3month","weight":0.1446},{"period":"6month","weight":0.0577},{"period":"1year","weight":0.0671},{"period":"ytd","weight":0.0982}],"survey":" 上海奥浦迈生物科技股份有限公司是一家专门从事细胞培养产品与服务的高新技术企业。公司以细胞培养技术和工艺开发为基础,主营业务涉及细胞培养基系列产品和生物药委托开发生产服务两大应用领域。公司的主要产品有目培养基业务、CDMO业务、CHO培养基、293培养基。公司及其子公司已获得5项发明专利,62项实用新型专利和2项外观专利。公司获得“高新技术企业”、上海市“专精特新”、上海市科技小巨人培育企业等称号。","serverTime":1732303500346,"listedPrice":80.2,"stockholders":"3184人(较上一季度减少2.78%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"奥浦迈(688293)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供奥浦迈(688293)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"奥浦迈,688293,奥浦迈股票,奥浦迈股票老虎,奥浦迈股票老虎国际,奥浦迈行情,奥浦迈股票行情,奥浦迈股价,奥浦迈股市,奥浦迈股票价格,奥浦迈股票交易,奥浦迈股票购买,奥浦迈股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"奥浦迈(688293)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供奥浦迈(688293)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}